FTRE Q2 2025 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena

FTREFortrea Holdings Inc.

$851M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$710M+7.2% YoY

Gross Profit

$114M16.0% margin

Operating Income

-$11M-1.5% margin

Net Income

-$375M-52.8% margin

EPS (Diluted)

$-4.14

QoQ Revenue Growth

+9.1%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$14M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$2.2B

Stockholders' Equity

$589M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$710M	$662M	+7.2%
Gross Profit	$114M	$137M	-16.9%
Operating Income	-$11M	-$51M	+78.6%
Net Income	-$375M	-$138M	-170.9%

Revenue Segments

Clinical Services Segment

$710M100%

Geographic Segments

North America

$344M48%

Europe

$219M31%

Other Geographical Areas

$147M21%